Healthcare & Biotech Expert
Marc Lichtenfeld is the Director of Research for Access Research Group; Senior Analyst for the Xcelerated Profits Report and a specialist in biotechnology/healthcare.
After starting out as a trader at Carlin Equities, Marc moved onto the contrarian Avalon Research Group as a Senior Analyst. He also obtained his NASD Series 86 & 87 licenses (required for all sell-side analysts). At Weiss Research, he co-managed the Real Wealth Portfolio and beat the S&P 500 by 17% over a six month period.
Marc joined the team following a successful spell as Senior Columnist at TheStreet.com. A contrarian investor by nature, Marc loves to shoot holes in conventional thinking and take profits where nobody else is looking. He’s broken several major stories on biotech companies and his investment approach blends thorough fundamental research with the timing tools of technical analysis.
He’s currently in the final stages of obtaining his Chartered Market Technician credential.
Most Recent Articles:
- Overvalued Stocks: Don't Touch These Bloated Investments With a 10-Foot Pole
- Investing in the Biotech Sector: Here's An Easy Way to Profit from Biotech Stocks
- The Stock Market's Red Flags: Four Ways to Handle Potential Market Turmoil
Marc Lichtenfeld’s investment newsletters and trading services:
Editor, Access Reseach
Co-Editor, Xcelerated Profits Report
What is Marc Lichtenfeld working on right now?
One Small Company’s Revolutionary Device is Killing Cancer in 16 Minutes!
It’s truly remarkable – but after years of success treating cancer patients in just hours… this company has uncovered a startling breakthrough that has patients walking out of their procedure in as little as 16 minutes! The technology could hit mainstream news any day now. Read the full story to find out more, including how the few investors who get in now could generate tremendous profits in the months ahead…
More from Marc Lichtenfeld
What was the first dollar you ever earned?
Shoveling snow when I was 9.
What’s been the most satisfying dollar (or dollars) you’ve ever earned?
It’s a tie. There was the $300 I made buying my first stock, when I was 22 – I bought 50 shares of Harley Davidson at $18 and sold it a short time later at $24. I thought this stock market stuff was going to be easy. The other one was being paid by Don King to ring announce one of his shows.
What’s your favorite way to make money?
Finding stocks that Wall Street has not yet discovered or misunderstands is one of my favorites.
What’s the best investing advice you’ve given or ever heard?
Zig when others zag.
Additional Articles
You can view previous articles by Marc Lichtenfeld below, or explore the Investment U archives.
- Overvalued Stocks: Don't Touch These Bloated Investments With a 10-Foot Pole
- Investing in the Biotech Sector: Here's An Easy Way to Profit from Biotech Stocks
- The Stock Market's Red Flags: Four Ways to Handle Potential Market Turmoil
- The F.I.R.S.T. System: Searching For the "Holy Grail" of Investing
- Your Investment Portfolio: Crucial Investment Habits Every Investor Should Cultivate
- The Next Big Thing in Health Care: How to Profit From Immunotherapy & Regenerative Medicine
- From Fat to Fit: Six Stocks Set to Profit From a Slimmer America
- What Investors Can Learn From the Recent Celebrity Outburst
- A New Wave of "Beatle Mania"... Four Ways to Profit From The Beatles: Rock Band
- Three Ways to Stop Making Emotional Investment Decisions
- How to Unearth Explosive Small-Cap HealthCare Stocks
- Recommended Investment Books: Nine Invaluable Resources For Every Investor
- Pocketing Nice Dividends with Hot Small-Caps
- Partial Profit Taking: What To Do When You're Sitting On Explosive Gains
- Understanding Earnings Surprises: What to Look For & Their Meaning For Investors
|
Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed